Advertisement

  • Loading metrics

Open Access

Correction

Correction: Design and expression of a chimeric recombinant antigen (SsIR-Ss1a) for the serodiagnosis of human strongyloidiasis: Evaluation of performance, sensitivity, and specificity

  • Mostafa Omidian,
  • Zohreh Mostafavi-Pour,
  • Marzieh Asadi,
  • Meysam Sharifdini,
  • Navid Nezafat,
  • Ali Pouryousef,
  • Amir Savardashtaki,
  • Mortaza Taheri-Anganeh,
  • Fattaneh Mikaeili,
  • Bahador Sarkari
  • Article
  • Metrics
  • Comments
  • Media Coverage

In the Introduction of this article [1], a citation [2] (reference 32 of [1]) is omitted from the first sentence of the fourth paragraph.

The correct sentence is: So far, several recombinant antigens have been produced and evaluated for the diagnosis of strongyloidiasis, of which a 31-kDa recombinant antigen (NIE), S. stercoralis immunoreactive antigen (SsIR), fatty acid and retinol-binding protein (FAR), 14-3-3 protein, and the recently introduced Ss1a-recombinant protein have received more attention [17–20, 32].

The reference is: Arifin N, Yunus MH, Nolan TJ, Lok JB, Noordin R (2018) Identification and preliminary evaluation of a novel recombinant protein for serodiagnosis of strongyloidiasis. The American Journal of Tropical Medicine and Hygiene. 98(4):1165–1170. doi: 10.4269/ajtmh.17-0697

References

  1. 1. Omidian M, Mostafavi-Pour Z, Asadi M, Sharifdini M, Nezafat N, Pouryousef A, et al. (2024) Design and expression of a chimeric recombinant antigen (SsIR-Ss1a) for the serodiagnosis of human strongyloidiasis: Evaluation of performance, sensitivity, and specificity. PLoS Negl Trop Dis 18(7): e0012320. https://doi.org/10.1371/journal.pntd.0012320 pmid:39008519
  2. 2. Arifin N, Yunus MH, Nolan TJ, Lok JB, Noordin R (2018) Identification and preliminary evaluation of a novel recombinant protein for serodiagnosis of strongyloidiasis. Am J Trop Med Hyg. 98(4): 1165–1170. pmid:29436335

Citation: Omidian M, Mostafavi-Pour Z, Asadi M, Sharifdini M, Nezafat N, Pouryousef A, et al. (2025) Correction: Design and expression of a chimeric recombinant antigen (SsIR-Ss1a) for the serodiagnosis of human strongyloidiasis: Evaluation of performance, sensitivity, and specificity. PLoS Negl Trop Dis 19(1): e0012838. https://doi.org/10.1371/journal.pntd.0012838

Published: January 29, 2025

Copyright: © 2025 Omidian et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.